Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
British Journal of Pharmacology|May 14, 1999
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometryM D Wood, K L Murkitt, M Ho, et al.Proceedings of the National Academy of Sciences of the United States of America|June 15, 1992
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtypeG McAllister, A Charlesworth, C Snodin, et al.European Journal of Pharmacology|October 29, 1991
Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptorL J Bristow, L Baucutt, L Thorn, et al.Journal of Medicinal Chemistry|December 1, 1987
Synthesis and 5-hydroxytryptamine antagonist activity of 2-[[2-(dimethylamino)ethyl]thio]-3-phenylquinoline and its analoguesT P Blackburn, B Cox, A J Guildford, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|August 29, 2000
The effect of SB-236057-A, a selective 5-HT1B receptor inverse agonist, on in vivo extracellular 5-HT levels in the freely-moving guinea-pigC Roberts, P Hatcher, J J Hagan, et al.Genomics|August 17, 2000
Molecular cloning and characterization of two novel retinoic acid-inducible orphan G-protein-coupled receptors (GPRC5B and GPRC5C)M J Robbins, D Michalovich, J Hill, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|September 26, 1997
Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptorsE Schlicker, K Fink, G J Molderings, et al.British Journal of Pharmacology|November 1, 1993
L-694,247: a potent 5-HT1D receptor agonistM S Beer, J A Stanton, Y Bevan, et al.British Journal of Pharmacology|August 1, 1997
Characterization of the binding of [3H]-SB-204269, a radiolabelled form of the new anticonvulsant SB-204269, to a novel binding site in rat brain membranesH J Herdon, J C Jerman, T O Stean, et al.European Journal of Pharmacology|August 12, 1999
SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptorD N Middlemiss, M Göthert, E Schlicker, et al.Pageof 11